{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:11Z","timestamp":1791216491028,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Pfizer Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s10620-022-07388-w","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T15:02:49Z","timestamp":1644678169000},"page":"5195-5205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4321-7774","authenticated-orcid":false,"given":"Mikihiro","family":"Fujiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Isogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Hiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritoshi","family":"Yoshii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,12]]},"reference":[{"key":"7388_CR1","unstructured":"McDowell C, Farooq U, Haseeb M. Inflammatory bowel disease (IBD). In: StatPearls [Internet], Treasure Island, FL; StatPearls Publishing;2020."},{"key":"7388_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00535-009-0057-3","volume":"44","author":"K Asakura","year":"2009","unstructured":"Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn\u2019s disease in Japan. J Gastroenterol. 2009;44:659\u2013665.","journal-title":"J Gastroenterol."},{"key":"7388_CR3","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s00535-019-01603-8","volume":"54","author":"Y Murakami","year":"2019","unstructured":"Murakami Y, Nishiwaki Y, Oba MS et al. Estimated prevalence of ulcerative colitis and Crohn\u2019s disease in Japan in 2014: an analysis of a nationwide survey. J Gastroenterol. 2019;54:1070\u20131077.","journal-title":"J Gastroenterol."},{"key":"7388_CR4","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/apt.12294","volume":"37","author":"H Yuhara","year":"2013","unstructured":"Yuhara H, Steinmaus C, Corley D et al. Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37:953\u2013962.","journal-title":"Aliment Pharmacol Ther."},{"key":"7388_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.thromres.2009.10.012","volume":"125","author":"S Saibeni","year":"2010","unstructured":"Saibeni S, Saladino V, Chantarangkul V et al. Increased thrombin generation in inflammatory bowel diseases. Thromb Res. 2010;125:278\u2013282.","journal-title":"Thromb Res."},{"key":"7388_CR6","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/j.1572-0241.2008.02052.x","volume":"103","author":"GC Nguyen","year":"2008","unstructured":"Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:2272\u20132280.","journal-title":"Am J Gastroenterol."},{"key":"7388_CR7","unstructured":"Office of the Surgeon General (US), National Heart Lung and Blood Institute (US). INTRODUCTION: Definitions of deep vein thrombosis and pulmonary embolism. In: The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism, Rockville, MD; Office of the Surgeon General (US);2008."},{"key":"7388_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2174\/1389450115666141109213152","volume":"16","author":"M W\u0142odarczyk","year":"2015","unstructured":"W\u0142odarczyk M, Sobolewska A, Fichna J, Wi\u015bniewska-Jarosi\u0144ska M. Prevention and therapeutic strategies of thromboembolic events in patients with inflammatory bowel diseases: a report of three cases. Curr Drug Targets. 2015;16:194\u2013198.","journal-title":"Curr Drug Targets."},{"key":"7388_CR9","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1080\/00365521.2016.1185464","volume":"51","author":"A Alatri","year":"2016","unstructured":"Alatri A, Schoepfer A, Fournier N et al. Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort. Scand J Gastroenterol. 2016;51:1200\u20131205.","journal-title":"Scand J Gastroenterol."},{"key":"7388_CR10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1097\/MIB.0000000000000274","volume":"21","author":"T Purnak","year":"2015","unstructured":"Purnak T, Yuksel O. Overview of venous thrombosis in inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1195\u20131203.","journal-title":"Inflamm Bowel Dis."},{"key":"7388_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","volume":"375","author":"MJ Grainge","year":"2010","unstructured":"Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375:657\u2013663.","journal-title":"Lancet."},{"key":"7388_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","volume":"10","author":"M Harbord","year":"2016","unstructured":"Harbord M, Annese V, Vavricka SR et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10:239\u2013254.","journal-title":"J Crohns Colitis."},{"issue":"Suppl 4","key":"7388_CR13","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S0049-3848(09)70136-7","volume":"123","author":"RH White","year":"2009","unstructured":"White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123:S11\u201317.","journal-title":"Thromb Res."},{"key":"7388_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1055\/s-0037-1615600","volume":"85","author":"CN Bernstein","year":"2001","unstructured":"Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001;85:430\u2013434.","journal-title":"Thromb Haemost."},{"key":"7388_CR15","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/gut.2010.228585","volume":"60","author":"MD Kappelman","year":"2011","unstructured":"Kappelman MD, Horvath-Puho E, Sandler RS et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut. 2011;60:937\u2013943.","journal-title":"Gut."},{"key":"7388_CR16","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s00535-004-1426-6","volume":"39","author":"K Sonoda","year":"2004","unstructured":"Sonoda K, Ikeda S, Mizuta Y, Miyahara Y, Kohno S. Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease. J Gastroenterol. 2004;39:948\u2013954.","journal-title":"J Gastroenterol."},{"key":"7388_CR17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.5217\/ir.2018.16.3.416","volume":"16","author":"K Ando","year":"2018","unstructured":"Ando K, Fujiya M, Nomura Y et al. The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study. Intest Res. 2018;16:416\u2013425.","journal-title":"Intest Res."},{"key":"7388_CR18","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1093\/ibd\/izy058","volume":"24","author":"MT Weng","year":"2018","unstructured":"Weng MT, Park SH, Matsuoka K et al. Incidence and risk factor analysis of thromboembolic events in East Asian patients with inflammatory bowel disease, a multinational collaborative study. Inflamm Bowel Dis. 2018;24:1791\u20131800.","journal-title":"Inflamm Bowel Dis."},{"key":"7388_CR19","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1160\/TH17-02-0134","volume":"117","author":"LH Lee","year":"2017","unstructured":"Lee LH, Gallus A, Jindal R, Wang C, Wu CC. Incidence of venous thromboembolism in Asian populations: a systematic review. Thromb Haemost. 2017;117:2243\u20132260.","journal-title":"Thromb Haemost."},{"key":"7388_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/ecco-jcc\/jjx162","volume":"12","author":"P Sarlos","year":"2018","unstructured":"Sarlos P, Szemes K, Hegyi P et al. Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease: a meta-analysis. J Crohns Colitis. 2018;12:489\u2013498.","journal-title":"J Crohns Colitis."},{"key":"7388_CR21","first-page":"533","volume":"3","author":"AT Rocha","year":"2007","unstructured":"Rocha AT, Paiva EF, Lichtenstein A, Milani R Jr, Cavalheiro CF, Maffei FH. Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag. 2007;3:533\u2013553.","journal-title":"Vasc Health Risk Manag."},{"key":"7388_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/1076029616632906","volume":"23","author":"H Alkim","year":"2017","unstructured":"Alkim H, Koksal AR, Boga S, Sen I, Alkim C. Etiopathogenesis, prevention, and treatment of thromboembolism in inflammatory bowel disease. Clin Appl Thromb Hemost. 2017;23:501\u2013510.","journal-title":"Clin Appl Thromb Hemost."},{"key":"7388_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","volume":"117","author":"W Ageno","year":"2008","unstructured":"Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008;117:93\u2013102.","journal-title":"Circulation."},{"key":"7388_CR24","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1161\/CIRCULATIONAHA.106.649954","volume":"115","author":"S Eichinger","year":"2007","unstructured":"Eichinger S, Pecheniuk NM, Hron G et al. High-density lipoprotein and the risk of recurrent venous thromboembolism. Circulation. 2007;115:1609\u20131614.","journal-title":"Circulation."},{"key":"7388_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12876-018-0892-x","volume":"18","author":"J Mahlich","year":"2018","unstructured":"Mahlich J, Matsuoka K, Sruamsiri R. Biologic treatment of Japanese patients with inflammatory bowel disease. BMC Gastroenterol. 2018;18:160.","journal-title":"BMC Gastroenterol."},{"key":"7388_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/MIB.0000000000000007","volume":"20","author":"EA Scoville","year":"2014","unstructured":"Scoville EA, Konijeti GG, Nguyen DD, Sauk J, Yajnik V, Ananthakrishnan AN. Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors. Inflamm Bowel Dis. 2014;20:631\u2013636.","journal-title":"Inflamm Bowel Dis."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07388-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07388-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07388-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T05:15:29Z","timestamp":1666415729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07388-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,12]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["7388"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07388-w","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,12]]},"assertion":[{"value":"23 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.F. has received grants from Fuji Chemical Industries Co., Ltd., JIMRO Co., Ltd., Kamui Pharma Inc., Nobelpharma Co., Ltd., and Yakult Honsha Co., Ltd.; grants and personal fees from AbbVie Inc, AYUMI Pharmaceutical Corporation, Bristol-Myers Squibb, Daiichi Sankyo Co., Ltd., EA Pharma Co., Ltd., Janssen Pharmaceutical K.K., Kyorin Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Pfizer Inc, Takeda Pharmaceutical Co., Ltd., and ZERIA Pharmaceutical Co., Ltd.; and personal fees from Aspen Japan K.K., AstraZeneca.co.jp, Boehringer Ingelheim GmbH, Celltrion Healthcare Japan Co., Ltd., Chugai Pharmaceutical Co., Ltd., Horii Pharmaceutical Ind., Ltd., Kissei Pharmaceutical Co., Ltd., Medical Tribune, Inc., Nobelpharma Co., Ltd., Olympus Co., Ltd., Sanofi K.K., Shionogi & Co., Ltd., Taiho Pharmaceutical Co., Ltd., Technical Information Institute Co., Ltd., and Teijin Pharma Ltd. T.K. is a former employee and stockholder of Pfizer Inc, and is a current employee of Eli Lilly and Company. S.A., S.H., F.M., and S.Y. are employees and stockholders of Pfizer Inc. N.I. and N.Y. are former employees and stockholders of Pfizer Inc. M.N. has received lecture fees from Daiichi Sankyo Co., Ltd. K.M. has received grants and personal fees from AbbVie Inc, EA Pharma Co., Ltd., Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nipponn Kayaku Co., Ltd., Pfizer Inc, Sekisui Medical Co., Ltd., Takeda Pharmaceutical Co., Ltd.; and personal fees from Alfresa Pharma Corporation, Gilead Sciences, Inc., GlaxoSmithKline plc, Janssen Pharmaceutical K.K., JIMRO Co., Ltd., MIYARISAN Pharmaceutical Co., Ltd., Thermo Fisher Scientific Inc., and ZERIA Pharmaceutical Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}